Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.340
+0.030 (0.91%)
At close: Sep 11, 2026, 4:00 PM EDT
3.400
+0.060 (1.80%)
After-hours: Sep 11, 2026, 4:10 PM EDT
Adagene Market Cap
Adagene has a market cap or net worth of $224.26 million as of September 11, 2026. Its market cap has increased by 99.09% in one year.
Market Cap
224.26M
Enterprise Value
102.44M
1-Year Change
99.09%
Ranking
Category
Stock Price
$3.34
ChartMarket Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $224.26M, a decrease of -72.11%. That is a compound annual growth rate of -20.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 224.26M | 151.76% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 228.70M |
| Surrozen | 228.61M |
| Eledon Pharmaceuticals | 226.13M |
| Protara Therapeutics | 223.97M |
| Keros Therapeutics | 221.47M |
| Greenwich LifeSciences | 221.05M |
| Protalix BioTherapeutics | 219.96M |
| Sol-Gel Technologies | 218.67M |